Pathogenesis and Treatment of Graft-Versus-Host Disease After Bone Marrow Transplant

Georgia B. Vogelsang; Linda Lee; Debra M. Bensen-Kennedy

doi:10.1146/annurev.med.54.101601.152339

Pathogenesis and Treatment of Graft-Versus-Host Disease After Bone Marrow Transplant

Georgia B. Vogelsang, Linda Lee, Debra M. Bensen-Kennedy

School of Medicine

Research output: Contribution to journal › Review article

Abstract

Stem cell transplantation is being used to treat a number of hematologic malignancies as well as hematologic and immune deficiency states. The ages of patients being offered this therapy and the donor marrow sources have been expanded. One persistent problem has been graft-versus-host disease (GVHD). This article reviews the basic biology of GVHD, clinical manifestations of acute and chronic GVHD, prophylaxis and treatment of acute GVHD, and treatment of chronic GVHD.

Original language	English (US)
Pages (from-to)	29-52
Number of pages	24
Journal	Annual review of medicine
Volume	54
DOIs	https://doi.org/10.1146/annurev.med.54.101601.152339
State	Published - Nov 19 2003

Fingerprint

Keywords

Donor lymphocyte infusion
Prednisone
Sclerodermatous
Stem cell transplantation

ASJC Scopus subject areas

Biochemistry, Genetics and Molecular Biology(all)

Cite this

Vogelsang, G. B., Lee, L., & Bensen-Kennedy, D. M. (2003). Pathogenesis and Treatment of Graft-Versus-Host Disease After Bone Marrow Transplant. Annual review of medicine, 54, 29-52. https://doi.org/10.1146/annurev.med.54.101601.152339

@article{4def5682110e4941995d5d6aadf1c7cd,

title = "Pathogenesis and Treatment of Graft-Versus-Host Disease After Bone Marrow Transplant",

abstract = "Stem cell transplantation is being used to treat a number of hematologic malignancies as well as hematologic and immune deficiency states. The ages of patients being offered this therapy and the donor marrow sources have been expanded. One persistent problem has been graft-versus-host disease (GVHD). This article reviews the basic biology of GVHD, clinical manifestations of acute and chronic GVHD, prophylaxis and treatment of acute GVHD, and treatment of chronic GVHD.",

keywords = "Donor lymphocyte infusion, Prednisone, Sclerodermatous, Stem cell transplantation",

author = "Vogelsang, {Georgia B.} and Linda Lee and Bensen-Kennedy, {Debra M.}",

year = "2003",

month = nov,

day = "19",

doi = "10.1146/annurev.med.54.101601.152339",

language = "English (US)",

volume = "54",

pages = "29--52",

journal = "Annual Review of Medicine",

issn = "0066-4219",

publisher = "Annual Reviews Inc.",

}

TY - JOUR

T1 - Pathogenesis and Treatment of Graft-Versus-Host Disease After Bone Marrow Transplant

AU - Vogelsang, Georgia B.

AU - Lee, Linda

AU - Bensen-Kennedy, Debra M.

PY - 2003/11/19

Y1 - 2003/11/19

N2 - Stem cell transplantation is being used to treat a number of hematologic malignancies as well as hematologic and immune deficiency states. The ages of patients being offered this therapy and the donor marrow sources have been expanded. One persistent problem has been graft-versus-host disease (GVHD). This article reviews the basic biology of GVHD, clinical manifestations of acute and chronic GVHD, prophylaxis and treatment of acute GVHD, and treatment of chronic GVHD.

AB - Stem cell transplantation is being used to treat a number of hematologic malignancies as well as hematologic and immune deficiency states. The ages of patients being offered this therapy and the donor marrow sources have been expanded. One persistent problem has been graft-versus-host disease (GVHD). This article reviews the basic biology of GVHD, clinical manifestations of acute and chronic GVHD, prophylaxis and treatment of acute GVHD, and treatment of chronic GVHD.

KW - Donor lymphocyte infusion

KW - Prednisone

KW - Sclerodermatous

KW - Stem cell transplantation

UR - http://www.scopus.com/inward/record.url?scp=0037978047&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037978047&partnerID=8YFLogxK

U2 - 10.1146/annurev.med.54.101601.152339

DO - 10.1146/annurev.med.54.101601.152339

M3 - Review article

C2 - 12359826

AN - SCOPUS:0037978047

VL - 54

SP - 29

EP - 52

JO - Annual Review of Medicine

JF - Annual Review of Medicine

SN - 0066-4219

ER -

Access to Document

10.1146/annurev.med.54.101601.152339